Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

BioElectronics Is Filing For 510(k) Clearance With FDA For Its AllayTM Product
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced it is filing an application with the U.S. Food and Drug Administration (FDA) for 510(k) clearance to market its Allay™ Menstrual Pain Relief Patch product. The filing follows a very successful double blinded, placebo controlled clinical trial in which 71% of women in the active group reported either complete elimination or a reduction in their typical menstrual pain symptoms, with 49% showing at least a 50% reduction in pain associated with dysmenorrhea.
generic viagra online
AARP Thanks Vice President Biden, Administration, For Working To Improve Health Care For Older Americans
This afternoon, AARP CEO A. Barry Rand delivered the following remarks at the White House Middle Class Task Force Town Hall in Alexandria, Va., during a discussion with Vice President Biden, Health and Human Services Secretary Kathleen Sebelius, and White House Office of Health Reform Director Nancy-Ann DeParle, on how health care reform will lower costs, cut waste, and improve quality for seniors from across the country.
News of the day
Red Wine Ingredient Demonstrates Significant Health Benefits: Research Review
The benefits of alcohol are all about moderation. Low to moderate drinking - especially of red wine - appears to reduce causes of mortality, while too much drinking causes multiple organ damage.
Health Insurance

Natural Orifice Translumenal Endoscopic Surgery® Research Benefits From Increased Grant From NOSCAR

The Natural Orifice Surgery Consortium for Assessment and Research® (NOSCAR®), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), has announced Olympus" continuing commitment to funding research in an emerging minimally invasive transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery®, with a $250,000 grant to the existing Olympus Research Fund supporting NOTES® research. This grant increases Olympus" total funding to $1.25 million. NOTES, which is performed by using the patient"s natural openings for surgery, was discussed among more than 250 medical experts, researchers and physicians, from July 9-11, 2009 at the 4th International NOSCAR Conference on NOTES in Boston, Massachusetts. "NOSCAR is grateful to Olympus Medical Systems Corporation for supporting NOTES research and helping to advance this minimally invasive technique," said Steven D. Schwaitzberg, MD, NOSCAR Research Subcommittee Co-Chair. "For the third consecutive year Olympus, a world leader in endoscopy, is proud to support the pioneering effort of NOTES research," said Haruhito Morishima, President, Olympus Medical Systems Corporation. "As a company committed to surgical innovation and to the advancement of less invasive patient care, we believe that funding the responsible, effective and safe development of this new modality may lead to an approach that could ultimately represent a major paradigm shift in minimally invasive therapy." "We continue to receive an outstanding response for basic research funding reflecting the momentum this revolutionary technique has created," said Michael L. Kochman, MD, NOSCAR Research Subcommittee Co-Chair. In July 2008, NOSCAR leadership granted funds to determine topics requiring further basic research in order to make the NOTES platform feasible. That grant, used for research called the Delphi Study, gathered data from physicians and researchers around the world to identify those areas requiring additional research and investigation. The topics to be funded will be announced when the call for submissions is sent later this month. Anne Brownsey American Society for Gastrointestinal Endoscopy


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009